Bone-site-specific responses to zoledronic acid.

Area of Science:

• Bone biology
• Pharmacology
• Osteoporosis treatment

Background:

• Bisphosphonates are crucial for treating bone diseases like osteoporosis.
• A known side effect of bisphosphonates is osteonecrosis of the jaw (ONJ).
• Understanding site-specific effects on bone turnover is critical.

Purpose of the Study:

• To investigate differential effects of bisphosphonates on long bone versus jaw osteoclasts and bone turnover.
• To explore the mechanisms behind bisphosphonate-induced osteonecrosis of the jaw.

Main Methods:

• Female mice received weekly intraperitoneal zoledronic acid (0.5 mg/kg) for up to 6 months.
• Evaluated osteoclast numbers, bone mineralization, and bone formation in long bones and the jaw.
• Assessed bone marrow cell counts and potential for molar root resorption.

Main Results:

• Zoledronic acid reduced jaw bone marrow cells but not long bone marrow cells.
• Osteoclast numbers remained unaffected in vivo, yet bone volume and density increased in both sites.
• Bone formation was suppressed in long bones after 6 months, but not in the jaw.
• Bisphosphonates induced molar root resorption via active osteoclasts.

Conclusions:

• Bisphosphonates exhibit site-specific effects on bone turnover.
• The study elucidates aspects of osteonecrosis of the jaw etiology.
• Bisphosphonates can activate osteoclast activity specifically at molar roots.